Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lewis

Showing results (941-950 of 1,038) with videos related to

Pageof 104
Sort By:
JCI Insight|July 15, 2025
Effects of FGF21, soluble TGFBR2, and environmental temperature on metabolic dysfunction in lipodystrophic miceJessica N Maung, Yang Chen, Keegan S Hoose, et al.
Brain, Behavior, and Immunity|September 11, 2020
Sex differences in the inflammatory response to stress and risk of adverse cardiovascular outcomes among patients with coronary heart diseaseSamaah Sullivan, An Young, Muhammad Hammadah, et al.
Journal of the American Heart Association|September 30, 2020
Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working GroupHolly C Gooding, Samuel S Gidding, Andrew E Moran, et al.
Cell Reports|December 9, 2025
eIF3d and eIF3e mediate selective translational control of hypoxia that can be inhibited by small moleculesStephen C Purdy, Kate Matlin, Christopher Alderman, et al.
Journal of Medicinal Chemistry|April 14, 2006
A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxietyRichard T Lewis, Wesley P Blackaby, Timothy Blackburn, et al.
Contemporary Clinical Trials|June 12, 2024
Protocol of the HARMONY study: A culturally relevant, randomized-controlled, stress management intervention to reduce cardiometabolic risk in African American womenCheryl L Woods-Giscombe, Susan Gaylord, Andrew Bradford, et al.
Neuro-Oncology Advances|July 25, 2022
Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinibYeshavanth Kumar Banasavadi-Siddegowda, Sriya Namagiri, Yoshihiro Otani, et al.
Neuro-Oncology|February 8, 2021
Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastomaYoshihiro Otani, Hannah P Sur, Guruprasad Rachaiah, et al.
Journal of Medicinal Chemistry|June 28, 2012
The discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (ALK) inhibitors with potential utility for the treatment of cancerRichard T Lewis, Christiane M Bode, Deborah M Choquette, et al.
Analytical Chemistry|June 29, 2022
Internal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in PlasmaJacob J Kennedy, Jeffrey R Whiteaker, Richard G Ivey, et al.
Pageof 104

Showing results (941-950 of 1,038) with videos related to

Sort By:
Pageof 104
JCI Insight|July 15, 2025
Effects of FGF21, soluble TGFBR2, and environmental temperature on metabolic dysfunction in lipodystrophic miceJessica N Maung, Yang Chen, Keegan S Hoose, et al.
Brain, Behavior, and Immunity|September 11, 2020
Sex differences in the inflammatory response to stress and risk of adverse cardiovascular outcomes among patients with coronary heart diseaseSamaah Sullivan, An Young, Muhammad Hammadah, et al.
Journal of the American Heart Association|September 30, 2020
Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working GroupHolly C Gooding, Samuel S Gidding, Andrew E Moran, et al.
Cell Reports|December 9, 2025
eIF3d and eIF3e mediate selective translational control of hypoxia that can be inhibited by small moleculesStephen C Purdy, Kate Matlin, Christopher Alderman, et al.
Journal of Medicinal Chemistry|April 14, 2006
A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxietyRichard T Lewis, Wesley P Blackaby, Timothy Blackburn, et al.
Contemporary Clinical Trials|June 12, 2024
Protocol of the HARMONY study: A culturally relevant, randomized-controlled, stress management intervention to reduce cardiometabolic risk in African American womenCheryl L Woods-Giscombe, Susan Gaylord, Andrew Bradford, et al.
Neuro-Oncology Advances|July 25, 2022
Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinibYeshavanth Kumar Banasavadi-Siddegowda, Sriya Namagiri, Yoshihiro Otani, et al.
Neuro-Oncology|February 8, 2021
Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastomaYoshihiro Otani, Hannah P Sur, Guruprasad Rachaiah, et al.
Journal of Medicinal Chemistry|June 28, 2012
The discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (ALK) inhibitors with potential utility for the treatment of cancerRichard T Lewis, Christiane M Bode, Deborah M Choquette, et al.
Analytical Chemistry|June 29, 2022
Internal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in PlasmaJacob J Kennedy, Jeffrey R Whiteaker, Richard G Ivey, et al.
Pageof 104